Moriguchi, Japan

Noriko Yamamoto


Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 1995

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Noriko Yamamoto: Innovator in Neuroprotective Drug Development

Introduction

Noriko Yamamoto is a prominent inventor based in Moriguchi, Japan. She has made significant contributions to the field of neuroprotective drugs, showcasing her expertise and dedication to advancing medical science. Her innovative work focuses on developing treatments that address brain dysfunction caused by various conditions.

Latest Patents

Noriko Yamamoto holds a patent for a neuroprotective drug. This drug comprises as an essential active ingredient ethyl 2-[4,5-bis(4-methoxyphenyl)thiazol-2-yl]pyrrol-1-yl acetate. It is designed to provide high safety for the prophylaxis and treatment of brain dysfunction induced by hypoxia due to disturbances in cerebral circulation, such as cerebral hemorrhage or cerebral infarction in humans. This patent highlights her commitment to improving patient outcomes through innovative pharmaceutical solutions.

Career Highlights

Noriko Yamamoto is currently employed at Kanebo, Limited, where she continues to work on groundbreaking research and development projects. Her career is marked by a focus on creating effective treatments that enhance brain health and functionality. Her dedication to her work has positioned her as a key figure in her field.

Collaborations

Noriko collaborates with esteemed colleagues, including Koichi Yokota and Akira Yamashita. These partnerships foster a collaborative environment that encourages the exchange of ideas and expertise, further enhancing the quality of their research and development efforts.

Conclusion

Noriko Yamamoto's contributions to the field of neuroprotective drugs exemplify her innovative spirit and commitment to advancing medical science. Her work not only addresses critical health issues but also paves the way for future advancements in neuroprotection.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…